Concepedia

Deborah F. Chapman

DF

12

Publications

1.1K

Citations

12

H-Index

1995

Active since

Affiliations

General Atomics (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of California San Diego

Deborah F. Chapman is an author at General Atomics (United States) specializing in neuropharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1995–2005

12

Publications

12

Metalloproteinase Inhibition Reduces Thrombolytic (Tissue Plasminogen Activator)–Induced Hemorrhage After Thromboembolic Stroke

Paul A. Lapchak, Deborah F. Chapman, Justin A. Zivin · Stroke · 2000 · 334 citations

In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine)

Jeffery J. Anderson, Margaret Bradbury, Darlene R. Giracello et al. · European Journal of Pharmacology · 2003 · 136 citations

, , +11

Dehydroepiandrosterone Sulfate Is Neuroprotective in a Reversible Spinal Cord Ischemia Model

Paul A. Lapchak, Deborah F. Chapman, Sonia Nunez et al. · Stroke · 2000 · 113 citations

Relationships between Organizational Culture and Organizational Performance

M. M. Petty, Nicholas A. Beadles, Deborah F. Chapman et al. · Psychological Reports · 1995 · 108 citations

, , +8

[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization

Jeffery J. Anderson, Sara Rao, Blake A. Rowe et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 107 citations · Full text

Rows per page

1–5 of 12